HARR STEVE

PrivateCIK: 1627387
Location

SEATTLE, WA

HARR STEVE (President & CEO) exercised options at SANA BIOTECHNOLOGY, INC.

Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.

M · 2 exercises
InsiderHARR STEVECIK 1627387
→
IssuerSANA BIOTECHNOLOGY, INC.CIK 1770121
DirectorOfficer· President & CEO
Since Feb 2021
-24.34K
Net shares
Net seller
$75.8K
Total sold
0
Open market trades
0B · 0S
6
Total transactions
91.67K acquired · 116.01K disposed
Non-Derivative Transactions4

Common Stock

Direct
M · Option Exercise

Shares

+41.67K

Price / share

—

Trade value

—

% of position

0.5%
3/6/2026
7.88M→7.92M

Common Stock

Direct
M · Option Exercise

Shares

+50K

Price / share

—

Trade value

—

% of position

0.6%
3/7/2026
7.92M→7.97M

Common Stock

Direct
F · Tax Withholding

Shares

−11.53K

Price / share

$3.13

Trade value

$36.08K

% of position

0.1%
3/9/2026
7.97M→7.96M

Common Stock

Direct
F · Tax Withholding

Shares

−12.82K

Price / share

$3.10

Trade value

$39.74K

% of position

0.2%
3/9/2026
7.96M→7.94M
Total

Net shares

+67.32K

Net value

-$75.82K

Derivative Transactions2

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

41.67K shares

Shares

−41.67K

Strike price

Held after

125K

Exercisable

—

3/6/2026

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

50K shares

Shares

−50K

Strike price

Held after

100K

Exercisable

—

3/7/2026
Non-Derivative Holdings (Post-Transaction)3

Common Stock

Indirect
Shares owned682.50K

Common Stock

Indirect
Shares owned167K

Common Stock

Indirect
Shares owned167K
Total
1.02M indirect1.02M
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
HARR STEVE — Insider Transaction (Form 4) Filed Mar 10, 2026 | Finecho